Splicing Patterns in SF3B1 -Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific Neoepitopes
- Fonction : Auteur
- PersonId : 770558
- ORCID : 0000-0003-2930-6073
- IdRef : 261885200
- Fonction : Auteur
- PersonId : 1196355
- ORCID : 0000-0001-6267-2353
- Fonction : Auteur
- PersonId : 1637405
- ORCID : 0000-0003-3899-2132
- IdRef : 119365340
- Fonction : Auteur
- PersonId : 1196356
- ORCID : 0000-0002-1132-9608
- Fonction : Auteur
- PersonId : 1196357
- ORCID : 0000-0002-2536-7680
- Fonction : Auteur
- PersonId : 797639
- ORCID : 0000-0002-3762-5050
- IdRef : 227577132
- Fonction : Auteur
- PersonId : 1196358
- ORCID : 0000-0001-8086-8544
- Fonction : Auteur
- PersonId : 792417
- ORCID : 0000-0001-9915-2810
- Fonction : Auteur
- PersonId : 762943
- ORCID : 0000-0002-9111-8842
- Fonction : Auteur
- PersonId : 1173377
- ORCID : 0000-0001-8583-8416
- IdRef : 101315058
- Fonction : Auteur
- PersonId : 769887
- ORCID : 0000-0002-5443-0802
- Fonction : Auteur
- PersonId : 1196359
- ORCID : 0000-0002-0060-1346
- Fonction : Auteur
- PersonId : 807138
- ORCID : 0000-0002-8100-2272
- IdRef : 074099191
- Fonction : Auteur
- PersonId : 756941
- ORCID : 0000-0003-3161-7719
- IdRef : 092426565
Résumé
Abstract Disruption of splicing patterns due to mutations of genes coding splicing factors in tumors represents a potential source of tumor neoantigens, which would be both public (shared between patients) and tumor-specific (not expressed in normal tissues). In this study, we show that mutations of the splicing factor SF3B1 in uveal melanoma generate such immunogenic neoantigens. Memory CD8+ T cells specific for these neoantigens are preferentially found in 20% of patients with uveal melanoma bearing SF3B1-mutated tumors. Single-cell analyses of neoepitope-specific T cells from the blood identified large clonal T-cell expansions, with distinct effector transcription patterns. Some of these expanded T-cell receptors are also present in the corresponding tumors. CD8+ T-cell clones specific for the neoepitopes specifically recognize and kill SF3B1-mutated tumor cells, supporting the use of this new family of neoantigens as therapeutic targets. Significance: Mutations of the splicing factor SF3B1 in uveal melanoma generate shared neoantigens that are uniquely expressed by tumor cells, leading to recognition and killing by specific CD8 T cells. Mutations in splicing factors can be sources of new therapeutic strategies applicable to diverse tumors. This article is highlighted in the In This Issue feature, p. 1861
